Children born with a tail-like appendage have a rare malformation that is frequently associated with abnormalities of the spine and spinal cord. A contiguous fibrolipoma is usually seen extending from the subcutaneous portion of the tail into the inferior spinal cord, resulting in tethered cord syndrome. We present the case of a child born with a tail and intraspinal lipoma that were not contiguous with each other, and were separated by an intact layer of lumbosacral fascia. The tail and lipoma were removed and the spinal cord untethered, and the child is neurologically normal 2 years after surgery. The absence of a contiguous lipoma from the tail to the spinal cord suggests that this condition may be principally caused by a disorder of secondary neurulation and/or regression of the normal embryonic tail bud. The embryology of the lower spine is reviewed and possible etiologies discussed.

Keywords:
Human tail, Spinal lipoma, Tethered spinal cord
1.
Ohhara Y: Human tail and other abnormalities of the lumbosacrococcygeal region relating to tethered cord syndrome. Ann Plast Surg 1980;4:507–510.
2.
Dubrow TJ, Wackym PA, Lesavoy MA: Detailing the human tail. Ann Plast Surg 1988;20:340–344.
3.
Lu FL, Wang P, Teng R, Yau KT: The human tail. Pediatr Neurol 1998;19:230–233.
4.
Gaskill SJ, Marlin AE: Neuroectodermal appendages: The human tail explained. Pediatr Neurosci 1989;15:95–99.
5.
Dao AH, Netsky MG: Human tails and pseudotails. Human Path 1984;15:449–453.
6.
Spiegelmann R, Schinder E, Mintz M, Blakstein A: The human tail: A benign stigma. J Neurosurg 1985;63:461–462.
7.
Chakrabortty S, Oi S, Yoshida Y, Yamada H, Yamaguchi M, Tamaki N, Matsumoto S: Myelomeningocele and thick filum terminale with tethered cord syndrome appearing as a human tail. J Neurosurg 1993;78:966–969.
8.
James HE, Canty TG: Human tails and associated spinal anomalies. Clin Pediatr (Phila) 1995;34:286–288.
9.
Belzberg AJ, Myles ST, Trevenen CL: The human tail and spinal dysraphism. J Ped Surg 1991;26:1243–1245.
10.
Ledley FD: Evolution and the human tail. N Engl J Med 1982;306:1212–1215.
11.
Ohara K, Nakamura K: Human tail. Br J Plast Surg 1994;47:288–289.
12.
Yamatani K, Saitoh T, Oi M, Oka N, Endoh T, Takaku A: A case of human tail. No Shinkei Geka 1991;19:93–96.
13.
Matsumoto S, Yamamoto T, Okura K: Human tail associated with lipomeningocele. Neurol Med Chir (Tokyo) 1994;34:44–47.
14.
Islam MK: Child with a tail. Indian J Pediatr 2002;69:819–820.
15.
Gonul E, Izci Y, Onguru O, Timurkaynak E, Seber N: The human tail associated with intraspinal lipoma: Case report. Minim Invasive Neurosurg 2000;43:215–218.
16.
Tavafoghi V, Ghandchi A, Hambrick GW, Uderhelyi GB: Cutaneous signs of spinal dysraphism: Report of a patient with a tail-like lipoma and review of 200 cases in the literature. Arch Dermatol 1978;114:573–577.
17.
Schut L, Bruce DA, Sutton LN: The management of the child with a lipomyelomeningocele. Clin Neurosurg 1983;30:464–476.
18.
Hoffman HJ, Taecholarn C, Hendrick EB, Humphreys RP: Management of lipomyelomeningoceles. J Neurosurg 1985;62:1–8.
19.
Moore KL: The Developing Human, revised. Philadelphia, WB Saunders, 1982.
20.
O’Rahilly R, Muller F: Human Embryology & Teratology, ed 3. New York, Wiley-Liss, 2001.
21.
Nievelstein RA, Hartwig NG, Vermeij-Keers C, Valk J: Embryonic development of the mammalian caudal neural tube. Teratology 1993;48:21–31.
22.
Sapunar D, Vilovic K, England M, Saraga-Babic M: Morphological diversity of dying cells during regression of the human tail. Ann Anat 2001;183:217–222.
23.
Saraga-Babic M, Lehtonen E, Svajger A, Wartiovaara J: Morphological and immunohistochemical characteristics of axial structures in the transitory human tail. Anat Anz 1994;176:277–286.
24.
Saraga-Babic M, Krolo M, Sapunar D, Terzic J, Biocic M: Differences in origin and fate between the cranial and caudal spinal cord during normal and disturbed human development. Acta Neuropathol (Berl) 1996;91:194–199.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.